Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-27Clinical Trial Update: Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns [Phase 4]
Phase 4 clinical trial update on bladder management in people with multiple sclerosis; the study status is completed and results were posted…
-
CLINICAL_TRIALS research · 2016-05-19Clinical Trial Update: Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures [NA]
This ClinicalTrials.gov update outlines a study evaluating sensor-based balance training and its impact on patient outcome measures. The stu…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Natalizumab Temporary Discontinuation Study [Phase 4]
A Phase 4 study assessing temporary discontinuation of natalizumab in people with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Allocentric Memory in MS and Resting State Functional MRI
A Yale University–sponsored clinical trial investigating allocentric memory in multiple sclerosis using resting-state functional MRI has com…
-
CLINICAL_TRIALS research · 2016-05-13Clinical Trial Update: Step it Up: An Exercise and Behaviour Change Programme for People With Multiple Sclerosis [NA]
This clinical trial update reports the completion of Step it Up, an exercise and behaviour-change programme for people with Multiple Scleros…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-05-12Clinical Trial Update: A Database Study to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada
A completed database study estimates the risk of developing multiple sclerosis following Arepanrix™ vaccination in Manitoba, Canada.
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Study of Electrical Impedance Myography (EIM) in ALS
This update reports on the completed clinical trial evaluating Electrical Impedance Myography (EIM) in amyotrophic lateral sclerosis and rel…
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Neuroretinal Biomarkers in Neurodegenerative Diseases
This clinical trial update notes the completion of a study evaluating neuroretinal biomarkers in neurodegenerative diseases, with multiple s…
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya [NA]
The trial update notes the completion of a clinical study evaluating computerized cognitive training for adults with multiple sclerosis who …
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Telerehabilitation Upper Extremity for Neurological Disorders [Phase 1]
Phase 1 trial update on a telerehabilitation program for upper-extremity function in people with neurological disorders, with completed stat…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: MSPT Device Usability Study
The MSPT device usability study in multiple sclerosis has completed.
-
CLINICAL_TRIALS research · 2016-05-03Clinical Trial Update: Motivation of Patients Diagnosed With Multiple Sclerosis to Become Citizen Researchers
A clinical trial update exploring the motivation of people diagnosed with Multiple Sclerosis to participate as citizen researchers.
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells
The clinical trial has completed. It evaluated the effect of glatiramer acetate on microRNA expression in antigen-presenting cells in multip…
-
FDA approval · 2016-04-19FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for BETASERON (interferon beta-1b) from Bayer HealthCare Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Aerobic Exercise and Flu-like Symptoms Following Interferon Beta 1a Injections in Patients With Multiple Sclerosis? [NA]
A completed clinical trial examining the effects of aerobic exercise on flu-like symptoms following interferon beta-1a injections in people …
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: A Cooperative Clinical Study of Abatacept in Multiple Sclerosis [Phase 2]
Phase 2 cooperative trial evaluating abatacept in relapsing-remitting multiple sclerosis has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Walking With FES or AFO in People With MS With Foot Drop
A completed clinical trial evaluating walking performance in people with multiple sclerosis and foot drop, comparing functional electrical s…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Comparison of Intermittent vs. Continuous Walking in MS [NA]
A completed clinical trial comparing intermittent versus continuous walking in people with multiple sclerosis to assess endurance outcomes.
-
CLINICAL_TRIALS research · 2016-03-31Clinical Trial Update: Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis [NA]
An update on a clinical trial evaluating lung volume recruitment to improve lung function and cough impairment in multiple sclerosis; sponso…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe) [Phase 1, Phase 2]
A double-blind Phase 1/2 trial evaluating rituximab given by intravenous and intrathecal injection versus placebo in low-inflammatory second…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS) [Phase 3]
Phase 3 clinical trial update on OnabotulinumtoxinA for urinary incontinence due to neurogenic detrusor overactivity in non-catheterizing MS…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone [Phase 2, Phase 3]
This update reports on a Phase 2/Phase 3 study evaluating adrenocorticotropic hormone to treat multiple sclerosis relapses after suboptimal …
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Robot-based Rehabilitation of Upper Limb Impairment in Multiple Sclerosis [NA]
The clinical trial evaluating robot-based rehabilitation for upper limb impairment in Multiple Sclerosis has completed.
-
FDA approval · 2016-03-14FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for COPAXONE (glatiramer acetate) submitted by Teva Neuroscience, Inc.
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis [Phase 2]
This document reports the completion and results posting of a Phase 2 trial evaluating the safety, tolerability, and efficacy of AIN457 in r…